Escherichia coli-asparaginase (Elspar) is superior to Erwinia-asparaginase (Erwinase) in childhood acute lymphoblastic leukaemia (ALL) induction--an early response study using minimal residual disease (MRD) markers

Ann Acad Med Singap. 2004 Sep;33(5 Suppl):S45-6.

Authors

C S N Kwok¹, S K Y Kham, H Ariffin, H P Lin, T C Quah, A E J Yeoh

Affiliation

¹ Division of Paediatric Haematology-Oncology, The Children's Medical Institute National University Hospital, National University of Singapore.

PMID: 15651203

No abstract available

Publication types

Comparative Study

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use*
Asparaginase / administration & dosage
Asparaginase / therapeutic use*
Child
Child, Preschool
Dickeya chrysanthemi / enzymology
Escherichia coli / enzymology
Humans
Infant
Lymphocytes / drug effects
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Remission Induction
Risk Assessment

Substances

Antineoplastic Agents
Asparaginase